1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine

C141H282F3N20O10+ — CID 159322794

IUPAC1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine
SMILESCC(C)(C)CC1CC(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)CCN1CCCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OC1CN(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)OCC(=O)CN1CCN(C(C)(C)C)CC1.CC(C)(C)OCC(CN1CCN(C(C)(C)C)CC1)C(F)(F)F.CC(C)(C)OCCCN1CCN(c2ccc(OC(C)(C)C)nc2)CC1.CC(C)(C)OCCN1CCOC2(CCN(C(C)(C)C)CC2)C1.CC(C)(C)OC[N+](C)(O)CN1CCN(C(C)(C)C)CC1
InChIInChI=1S/C21H43N3.C20H35N3O2.C19H38N2.C18H36N2O2.C17H35N3O.C16H31F3N2O.C15H34N3O2.C15H30N2O2/c1-20(2,3)10-15-22-11-7-12-23(17-16-22)18-19-8-13-24(14-9-19)21(4,5)6;1-19(2,3)24-15-7-10-22-11-13-23(14-12-22)17-8-9-18(21-16-17)25-20(4,5)6;1-18(2,3)15-17-13-16(14-17)7-8-20-9-11-21(12-10-20)19(4,5)6;1-16(2,3)20-9-7-18(8-10-20)15-19(12-14-22-18)11-13-21-17(4,5)6;1-16(2,3)20-11-9-18(10-12-20)7-8-19-13-15(14-19)21-17(4,5)6;1-14(2,3)21-9-7-20(8-10-21)11-13(16(17,18)19)12-22-15(4,5)6;1-14(2,3)17-10-8-16(9-11-17)12-18(7,19)13-20-15(4,5)6;1-14(2,3)17-9-7-16(8-10-17)11-13(18)12-19-15(4,5)6/h19H,7-18H2,1-6H3;8-9,16H,7,10-15H2,1-6H3;16-17H,7-15H2,1-6H3;7-15H2,1-6H3;15H,7-14H2,1-6H3;13H,7-12H2,1-6H3;19H,8-13H2,1-7H3;7-12H2,1-6H3/q;;;;;;+1;
InChIKeyWCNJNABQWLRKLK-UHFFFAOYSA-N
MW2474.93 g/mol
LogP23.60
Rot. Bonds33

About 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine

1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine (PubChem CID 159322794) has the molecular formula C141H282F3N20O10+ and a molecular weight of 2474.93 g/mol. Its IUPAC name is 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine.

Molecular Properties

Compound Name1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine
PubChem CID159322794
Molecular FormulaC141H282F3N20O10+
Molecular Weight2474.93 g/mol
Exact Mass2473.21
IUPAC Name1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine
SMILESCC(C)(C)CC1CC(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)CCN1CCCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OC1CN(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)OCC(=O)CN1CCN(C(C)(C)C)CC1.CC(C)(C)OCC(CN1CCN(C(C)(C)C)CC1)C(F)(F)F.CC(C)(C)OCCCN1CCN(c2ccc(OC(C)(C)C)nc2)CC1.CC(C)(C)OCCN1CCOC2(CCN(C(C)(C)C)CC2)C1.CC(C)(C)OC[N+](C)(O)CN1CCN(C(C)(C)C)CC1
InChIInChI=1S/C21H43N3.C20H35N3O2.C19H38N2.C18H36N2O2.C17H35N3O.C16H31F3N2O.C15H34N3O2.C15H30N2O2/c1-20(2,3)10-15-22-11-7-12-23(17-16-22)18-19-8-13-24(14-9-19)21(4,5)6;1-19(2,3)24-15-7-10-22-11-13-23(14-12-22)17-8-9-18(21-16-17)25-20(4,5)6;1-18(2,3)15-17-13-16(14-17)7-8-20-9-11-21(12-10-20)19(4,5)6;1-16(2,3)20-9-7-18(8-10-20)15-19(12-14-22-18)11-13-21-17(4,5)6;1-16(2,3)20-11-9-18(10-12-20)7-8-19-13-15(14-19)21-17(4,5)6;1-14(2,3)21-9-7-20(8-10-21)11-13(16(17,18)19)12-22-15(4,5)6;1-14(2,3)17-10-8-16(9-11-17)12-18(7,19)13-20-15(4,5)6;1-14(2,3)17-9-7-16(8-10-17)11-13(18)12-19-15(4,5)6/h19H,7-18H2,1-6H3;8-9,16H,7,10-15H2,1-6H3;16-17H,7-15H2,1-6H3;7-15H2,1-6H3;15H,7-14H2,1-6H3;13H,7-12H2,1-6H3;19H,8-13H2,1-7H3;7-12H2,1-6H3/q;;;;;;+1;
InChIKeyWCNJNABQWLRKLK-UHFFFAOYSA-N
XLogP23.60
TPSA182.35 Ų
H-Bond Donors1
H-Bond Acceptors29
Rotatable Bonds33
Heavy Atoms174
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002474.93
LogP ≤ 523.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine?
The IUPAC name of 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine (CID 159322794) is 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine.
What is the SMILES notation for 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine?
The canonical SMILES for 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine is CC(C)(C)CC1CC(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)CCN1CCCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OC1CN(CCN2CCN(C(C)(C)C)CC2)C1.CC(C)(C)OCC(=O)CN1CCN(C(C)(C)C)CC1.CC(C)(C)OCC(CN1CCN(C(C)(C)C)CC1)C(F)(F)F.CC(C)(C)OCCCN1CCN(c2ccc(OC(C)(C)C)nc2)CC1.CC(C)(C)OCCN1CCOC2(CCN(C(C)(C)C)CC2)C1.CC(C)(C)OC[N+](C)(O)CN1CCN(C(C)(C)C)CC1.
What is the InChIKey of 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine?
The InChIKey is WCNJNABQWLRKLK-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H43N3.C20H35N3O2.C19H38N2.C18H36N2O2.C17H35N3O.C16H31F3N2O.C15H34N3O2.C15H30N2O2/c1-20(2,3)10-15-22-11-7-12-23(17-16-22)18-19-8-13-24(14-9-19)21(4,5)6;1-19(2,3)24-15-7-10-22-11-13-23(14-12-22)17-8-9-18(21-16-17)25-20(4,5)6;1-18(2,3)15-17-13-16(14-17)7-8-20-9-11-21(12-10-20)19(4,5)6;1-16(2,3)20-9-7-18(8-10-20)15-19(12-14-22-18)11-13-21-17(4,5)6;1-16(2,3)20-11-9-18(10-12-20)7-8-19-13-15(14-19)21-17(4,5)6;1-14(2,3)21-9-7-20(8-10-21)11-13(16(17,18)19)12-22-15(4,5)6;1-14(2,3)17-10-8-16(9-11-17)12-18(7,19)13-20-15(4,5)6;1-14(2,3)17-9-7-16(8-10-17)11-13(18)12-19-15(4,5)6/h19H,7-18H2,1-6H3;8-9,16H,7,10-15H2,1-6H3;16-17H,7-15H2,1-6H3;7-15H2,1-6H3;15H,7-14H2,1-6H3;13H,7-12H2,1-6H3;19H,8-13H2,1-7H3;7-12H2,1-6H3/q;;;;;;+1;.
What are the key properties of 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine?
1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine has a molecular weight of 2474.93 g/mol, XLogP of 23.60, 33 rotatable bonds, 1 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 1-tert-butyl-4-[2-[3-(2,2-dimethylpropyl)cyclobutyl]ethyl]piperazine;1-tert-butyl-4-[2-[3-[(2-methylpropan-2-yl)oxy]azetidin-1-yl]ethyl]piperazine;9-tert-butyl-4-[2-[(2-methylpropan-2-yl)oxy]ethyl]-1-oxa-4,9-diazaspiro[5.5]undecane;(4-tert-butylpiperazin-1-yl)methyl-hydroxy-methyl-[(2-methylpropan-2-yl)oxymethyl]azanium;1-(4-tert-butylpiperazin-1-yl)-3-[(2-methylpropan-2-yl)oxy]propan-2-one;1-[(1-tert-butylpiperidin-4-yl)methyl]-4-(3,3-dimethylbutyl)-1,4-diazepane;1-tert-butyl-4-[3,3,3-trifluoro-2-[(2-methylpropan-2-yl)oxymethyl]propyl]piperazine;1-[3-[(2-methylpropan-2-yl)oxy]propyl]-4-[6-[(2-methylpropan-2-yl)oxy]-3-pyridinyl]piperazine is sourced from PubChem (CID 159322794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).